Hovione recognized as a Leading Contract Manufacturing Organization
Based on research from Industry Standard Research's Contract Manufacturing Quality Benchmarking annual online surveys, more than 125 contract manufacturers were evaluated on 23 different performance metrics. Research participants were recruited from biopharmaceutical companies of all sizes and were screened for decision-making influence and authority when it comes to working with contract manufacturing suppliers. Respondents only evaluated companies with which they have worked on an outsourced project in the past 18 months. This level of qualification ensures that quality ratings come from actual involvement with a business and that companies identified as leaders are backed by experiential data. CMOs have an opportunity to win these awards in up to three groups of outsourcing respondents - Big Pharma, Small Pharma, and Overall (combined Big and Small Pharma).
According to Life Science Leader magazine, in the 2020 CMO Leadership Awards, Hovione wins the following categories:
Outside of the core metrics of capabilities, compatibility, development, expertise, quality, and reliability, the Individual Attribute Awards identify common themes sponsor companies consider when choosing a supplier. And Hovione was recognized in
Hovione, the leader in spray drying and particle engineering, announced today an exclusive license agreement for a preclinical ophthalmology program, JX08, with Ji Xing Pharmaceuticals Limited (JIXING).
Hovione today announced the appointment of Dr. Jean-Luc Herbeaux as Hovione’s Chief Executive Officer, effective 1st April 2022
Hovione, the leader in spray drying and particle engineering, announced today a strategic partnership with Zerion Pharma to market and commercialize Dispersome®, Zerion´s proprietary solubility enhancement technology platform.